Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.63 USD | +0.16% | -0.05% | -2.66% |
Mar. 20 | Myriad Genetics Gets US Patent for SneakPeek Snap Device | MT |
Feb. 27 | Transcript : Myriad Genetics, Inc., Q4 2023 Earnings Call, Feb 27, 2024 |
Financials (USD)
Sales 2024 * | 828M | Sales 2025 * | 897M | Capitalization | 1.69B |
---|---|---|---|---|---|
Net income 2024 * | -91M | Net income 2025 * | -64M | EV / Sales 2024 * | 2.01 x |
Net cash position 2024 * | 21.96M | Net Debt 2025 * | 10.91M | EV / Sales 2025 * | 1.89 x |
P/E ratio 2024 * |
-20.1
x | P/E ratio 2025 * |
-30
x | Employees | 2,700 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.65% |
Latest transcript on Myriad Genetics, Inc.
1 day | +0.16% | ||
1 week | -0.05% | ||
Current month | -12.62% | ||
1 month | -16.23% | ||
3 months | -13.59% | ||
6 months | +19.42% | ||
Current year | -2.66% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Diaz
CEO | Chief Executive Officer | 61 | 20-08-12 |
Scott Leffler
DFI | Director of Finance/CFO | 49 | Jan. 28 |
Dale Muzzey
CTO | Chief Tech/Sci/R&D Officer | 44 | 14-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
S. Phanstiel
CHM | Chairman | 65 | 09-09-15 |
Paul Bisaro
BRD | Director/Board Member | 63 | 22-10-30 |
Dan Spiegelman
BRD | Director/Board Member | 65 | 20-05-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.24% | 16 M€ | -6.73% | ||
0.26% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 18.63 | +0.16% | 481,132 |
24-04-23 | 18.6 | +0.59% | 508,160 |
24-04-22 | 18.49 | -0.05% | 485,015 |
24-04-19 | 18.5 | -0.05% | 487,827 |
24-04-18 | 18.51 | -0.70% | 643,929 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.66% | 1.68B | |
-11.57% | 7.4B | |
+2.98% | 5.47B | |
+0.98% | 4.51B | |
+5.18% | 4.42B | |
-50.82% | 3.29B | |
+11.23% | 2.66B | |
-16.38% | 2.07B | |
-10.84% | 1.66B | |
-4.35% | 1.46B |
- Stock Market
- Equities
- MYGN Stock